These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26167891)

  • 1. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients.
    Walker IF; Shi O; Hicks JP; Elsey H; Wei X; Menzies D; Lan Z; Falzon D; Migliori GB; Pérez-Guzmán C; Vargas MH; García-García L; Sifuentes Osornio J; Ponce-De-León A; van der Walt M; Newell JN
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31073080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK; Das M; Daftary A
    PLoS One; 2016; 11(3):e0150849. PubMed ID: 26959366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.
    Kuchukhidze G; Kumar AM; de Colombani P; Khogali M; Nanava U; Blumberg HM; Kempker RR
    Public Health Action; 2014 Oct; 4(Suppl 2):S41-6. PubMed ID: 26393097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study.
    Patel SV; Nimavat KB; Alpesh PB; Shukla LK; Shringarpure KS; Mehta KG; Joshi CC
    J Infect Public Health; 2016; 9(4):478-84. PubMed ID: 26724262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study.
    Adamashvili N; Akopyan K; Tukvadze N; Dumchev K; Sereda Y; Khonelidze I; Kuchukhidze G
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.
    Moyo S; Cox HS; Hughes J; Daniels J; Synman L; De Azevedo V; Shroufi A; Cox V; van Cutsem G
    PLoS One; 2015; 10(3):e0118919. PubMed ID: 25785451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
    Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
    Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT; Guilatco RS; Guray CV; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
    Wai PP; Shewade HD; Kyaw NTT; Kyaw KWY; Thein S; Si Thu A; Oo MM; Htwe PS; Tun MMT; Win Maung HM; Soe KT; Aung ST
    PLoS One; 2017; 12(12):e0187223. PubMed ID: 29261669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.